| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 05/19/2005 | US20050107604 Reagent for determining the absolute configuration of chiral compound and determination method |
| 05/19/2005 | US20050107462 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/19/2005 | US20050107424 8-Azabicyclo[3.2.1]octane derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridines, used for modulating chemokine CCR5 receptors for treating retroviral infections and inflammatory diseases |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107415 Opioid and opioid-like compounds and uses thereof |
| 05/19/2005 | CA2544213A1 Imidazo[1,2-a]pyridine anxiolytics |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1202111C Large ring lactone antibiotic and preparing method thereof |
| 05/18/2005 | CN1202108C Spiro compounds, preparing method and intermediate |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | CA2335492C Pyrrolo[2,3-d]pyrimidine compounds |
| 05/12/2005 | WO2005042666A1 New compound capable of being used in organic layer of organic light emitting device |
| 05/12/2005 | WO2005042538A1 Spirofuropyridine aryl derivatives |
| 05/12/2005 | WO2005042535A1 Pyrrolobenzodiazepines |
| 05/12/2005 | WO2005042475A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/12/2005 | US20050101649 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy |
| 05/12/2005 | US20050101615 Pyridopyrimidine or naphthyridine derivative |
| 05/12/2005 | US20050100787 High density; stability; n-heterocyclic polymer or oligomer |
| 05/12/2005 | US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 05/12/2005 | CA2543436A1 Spirofuropyridine aryl derivatives |
| 05/12/2005 | CA2543322A1 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | CN1615335A Selective oxidation of sodium sulfide in kraft cooking liquors |
| 05/10/2005 | US6891016 Alkylenedioxythiophene dimers and trimers |
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate) |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/06/2005 | WO2005040174A1 Tetrahydro-furo`3,4-d!dioxole compounds and compositions and method for inhibiting platelet aggregation |
| 05/05/2005 | US20050096387 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/05/2005 | US20050096293 Analogs of nitrobenzylthioinosine |
| 05/04/2005 | EP1109812B1 Pyrrolobenzodiazepines |
| 05/04/2005 | CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/04/2005 | CN1612736A Imidazo (4, 3-e)-1, 2, 4-triazolo(1, 5-c) pyrimidines as adenosine A2A receptor antagonists |
| 05/04/2005 | CN1199973C Substituted carboblnie metal complex application |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 04/28/2005 | WO2005037842A1 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037711A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/28/2005 | US20050090540 E.g., 2,2-bis(hydroxymethyl)-1 -azabicyclo[2,2,2]octan-3-one and 2-hydroxymethyl-3,3-dihydroxy-1-azabicyclo[2,2,2]octane; these compounds reactivate the apoptosis-inducing function of mutant p53 proteins and are used to treat various types of tumors |
| 04/28/2005 | US20050090513 Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 04/28/2005 | US20050090499 Oral or injectable dosage forms; antiproliferative, anticarcinogenic, and antiinflammatory agents; ATP hydrolysis inhibition |
| 04/28/2005 | US20050090483 Purine derivatives as kinase inhibitors |
| 04/28/2005 | US20050089718 Pyran derivative |
| 04/28/2005 | CA2540195A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884799 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof |
| 04/21/2005 | US20050085494 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 04/21/2005 | US20050085481 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 04/21/2005 | US20050085475 Azabicyclylmethyl derivatives of 7,8-dihydro-1,6,9,-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050083391 Azo dye, image-forming coloring composition, ink for ink jet recording, heat-sensitive recording material, color toner and color filter |
| 04/20/2005 | EP1523778A2 Heteroatom-containing diamondoid transistors |
| 04/20/2005 | EP1523484A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/14/2005 | WO2005033107A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | US20050080085 Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof |
| 04/14/2005 | US20050079455 Colour photographic recording material |
| 04/14/2005 | US20050079387 Imidazole ring-containing compound and organic electroluminescence display device |
| 04/13/2005 | EP1522314A1 Remedies for diseases caused by vascular contraction or dilation |
| 04/13/2005 | EP1521745A1 Method for producing imidazolium salts |
| 04/13/2005 | EP1134222B1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 04/12/2005 | US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878705 Especially agents against viruses of the herpes family. |
| 04/07/2005 | US20050075361 Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions |
| 04/07/2005 | US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage |
| 04/07/2005 | US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one |
| 04/07/2005 | CA2540243A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 03/31/2005 | WO2005028480A2 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | WO2005014581A3 Lanthanide complexes preparation and uses thereof |
| 03/31/2005 | WO2004092172A3 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists |
| 03/31/2005 | WO2004092171A3 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists |
| 03/31/2005 | WO2004092170A3 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/31/2005 | US20050070569 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/31/2005 | US20050070558 For example, [4-(2,4-Dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetic acid; useful in preventing mast cell degranulation and therefore useful in treatment of diseases induced by activation of A2b receptor and mast cell activation such as asthma, allergic reactions |
| 03/31/2005 | US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 03/31/2005 | US20050070542 1-(1-Ethyl-propyl)-5-(2-methoxy-4-trifluoromethoxy-phenyl)-3,6-dimethyl-1H-pyrazolo[3,4-b]pyrazine; modulators of corticotropin releasing factor receptors; for treatment of central nervous system and periphereal disorders (stress, anxiety, depression, cardiovascular disorders, and eating disorders) |
| 03/31/2005 | US20050070541 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 03/31/2005 | US20050070525 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one |
| 03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/30/2005 | CN1194977C Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component |
| 03/29/2005 | CA2335186C Pyrrolo[2,3-d]pyrimidine compounds |
| 03/24/2005 | WO2005026175A1 Thienopyrazoles |